These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29066358)

  • 1. The bioengineering of stem cells to create dopamine replacement neurons is not the solution for Parkinson's.
    Carey RJ; Carey JL
    Pharmacol Biochem Behav; 2017 Dec; 163():36-37. PubMed ID: 29066358
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.
    Hallett PJ; Cooper O; Sadi D; Robertson H; Mendez I; Isacson O
    Cell Rep; 2014 Jun; 7(6):1755-61. PubMed ID: 24910427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous iPSC-derived dopamine neuron grafts show considerable promise in a nonhuman primate model of Parkinson's disease.
    Wakeman DR
    Mov Disord; 2015 Jul; 30(8):1034. PubMed ID: 26095814
    [No Abstract]   [Full Text] [Related]  

  • 5. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.
    Barker RA; Parmar M; Studer L; Takahashi J
    Cell Stem Cell; 2017 Nov; 21(5):569-573. PubMed ID: 29100010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease: fetal cell or stem cell derived treatments.
    Astradsson A; Aziz T
    BMJ; 2016 Jan; 352():h6340. PubMed ID: 26743154
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA
    N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract]   [Full Text] [Related]  

  • 10. Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?
    Björklund A; Lindvall O
    J Parkinsons Dis; 2017; 7(s1):S21-S31. PubMed ID: 28282811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain grafting may reverse loss of responsiveness to levodopa therapy in Parkinson's disease.
    Melamed E
    Clin Neuropharmacol; 1988 Feb; 11(1):77-82. PubMed ID: 3280129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of cell therapies and brain repair: Parkinson's disease leads the way.
    Petit GH; Olsson TT; Brundin P
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):60-70. PubMed ID: 24372386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.
    Hallett PJ; Deleidi M; Astradsson A; Smith GA; Cooper O; Osborn TM; Sundberg M; Moore MA; Perez-Torres E; Brownell AL; Schumacher JM; Spealman RD; Isacson O
    Cell Stem Cell; 2015 Mar; 16(3):269-74. PubMed ID: 25732245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From stem cells to dopamine neurons: developmental biology meets neurodegeneration.
    Tailor J; Andreska T; Kittappa R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):893-6. PubMed ID: 23131155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal-cell revival for Parkinson's.
    Abbott A
    Nature; 2014 Jun; 510(7504):195-6. PubMed ID: 24919900
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
    Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
    Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging between transplantation therapy and neurotrophic factors in Parkinson's disease.
    Ghosh B; Zhang C; Smith GM
    Front Biosci (Elite Ed); 2014 Jun; 6(2):225-35. PubMed ID: 24896204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
    Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
    Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.
    Takahashi H; Ishikawa H; Tanaka A
    Hum Cell; 2017 Apr; 30(2):60-71. PubMed ID: 28210976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.